Researches

South Egypt Cancer Institute

Assiut University

# Title Department Research Member Research Year
41 Nanocurcumin: A Promising Therapeutic Candidate for Experimental Trichinellosis Department of Pathology Saly Salah Abdelhakeem 2024
42 Exploring the efficacy of various wheat bran extracts in promoting burn wound healing: A comparative analysis Department of Clinical Pathology Dr. Asmaa Mohamed Zahran Omar 2024
43 Family strategies formanaging childhood cancer: Using traditional and complementarymedicine in Southern Egypt Department of Pediatric Oncology Ahmed Abdelwahab Faraag Mohammed 2024
44 Detection of ABL1 deletion without BCR-ABL rearrangement in ETP-ALL Department of Clinical Pathology Walaa Talaat Kamel 2024
45 Prognostic Value of Vitamin D Receptor in Patients with Metastatic Colorectal Cancer Received Irinotecan-Based Systemic Treatment as a Second Line Department of Medical Oncology Prof. Ashraf Zeidan Abdalla Ahmed 2024
46 Quantitative and qualitative Assessment of Superficial lymph nodes by B mode ultrasound, colour Doppler and sonoElastography Department of Radiology Dr. Hossam El-Din / Mostafa Kamel Mohamed 2024
47 Prognostic Value of Vitamin D Receptor in Patients with Metastatic Colorectal Cancer Received Irinotecan-Based Systemic Treatment as a Second Line Department of Medical Oncology Dr. Shimaa Hassan Shabaan Hassan 2024
48 High Dose Methotrexate Induced Toxicity in Children with Hematological Malignancy: Incidence and Relation to MTX Level Department of Pediatric Oncology Prof. Heba Abdel-Razik Sayed Hussein 2024
49 Prognostic Value of Erythropoietin-Producing Hepatocellular Receptor A2 (Epha2) Serum Marker in Colorectal Cancer Department of Medical Oncology Hadeer Mohamed Saad Elshazly 2024
50 The transcription factor ZEB-1 conveys chemoresistance in breast cancer Department of Medical Oncology Samar Abotaleb Mahmou 2024